Shenyang Xingqi Pharmaceutical Co., Ltd. (300573) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shenyang Xingqi Pharmaceutical Co., Ltd.

Why is Shenyang Xingqi Pharmaceutical Co., Ltd. ?

The company has declared Positive results for the last 5 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 771.22 MM
NET PROFIT(HY) At CNY 303.36 MM has Grown at 57.03%
ROCE(HY) Highest at 38.51%

With ROE of 34.62%, it has a fair valuation with a 4.48 Price to Book Value

Over the past year, while the stock has generated a return of 6.81%, its profits have risen by 68.4% ; the PEG ratio of the company is 0.7
At the current price, the company has a high dividend yield of 2.2

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Shenyang Xingqi Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shenyang Xingqi Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shenyang Xingqi Pharmaceutical Co., Ltd.

8.11%

-1.41

51.37%

China Shanghai Composite

21.43%

1.73

13.79%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

26.36%

EBIT Growth (5y)

40.01%

EBIT to Interest (avg)

91.89

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.18

Sales to Capital Employed (avg)

1.04

Tax Ratio

15.39%

Dividend Payout Ratio

41.36%

Pledged Shares

Institutional Holding

ROCE (avg)

25.75%

ROE (avg)

17.53%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.48

EV to EBIT

10.87

EV to EBITDA

9.86

EV to Capital Employed

5.50

EV to Sales

3.55

PEG Ratio

0.66

Dividend Yield

2.25%

ROCE (Latest)

50.60%

ROE (Latest)

34.62%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 771.22 MM

NET PROFIT(HY)

At CNY 303.36 MM has Grown at 57.03%

ROCE(HY)

Highest at 38.51%

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -4.78% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 8.71 times

NET SALES(Q)

At CNY 683.34 MM has Grown at 27.45%

-1What is not working for the Company

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.69 times

Here's what is working for Shenyang Xingqi Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 771.22 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit

At CNY 303.36 MM has Grown at 57.03%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Sales

At CNY 683.34 MM has Grown at 27.45%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Debtors Turnover Ratio

Highest at 8.71 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -4.78% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shenyang Xingqi Pharmaceutical Co., Ltd.

Inventory Turnover Ratio

Lowest at 2.69 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio